Unveiling the potential: Patient-derived organoids in cancer research and treatment
Patient-derived organoids (PDOs) represent a cutting-edge approach in cancer research that holds significant promise for revolutionizing various aspects of oncology.These Decorative Bottles three-dimensional structures, cultivated from patient tumor samples, faithfully mimic the intricate cellular composition and architecture of the original tumors